About Semprae Laboratories
Semprae Laboratories is a Healthcare company based in Saddle Brook (United States) founded in 2008, and was acquired by Innovus Pharma in December 2013. Producer of cold-pressed, natural oils and oil byproducts. Semprae Laboratories has raised $7.21 million across 2 funding rounds from investors including Innovus Pharma, Quaker Partners and BR Venture Fund. Semprae Laboratories offers products and services including Arousal Oil and 3 Single Use Packets. Its focus areas include Traditional Pharmaceuticals. Its legal entity is Zestra, Inc.
Company details
Semprae Laboratories was founded in 2008 and is based in Saddle Brook, United States. Operations focus on the production of cold-pressed oils derived from seeds and nuts, using a method without filtration additives to maintain nutritional properties. Oil cakes, serving as high-fiber byproducts, are also generated, along with seed and nut flours for culinary applications. Ecological practices and quality raw materials are prioritized throughout the process.
- Headquarters Saddle Brook, United States
- Stage Acquired
- SectorsHealthcare
- Website semprae.com
- Social LinkedIn
- Acquired by Innovus Pharma (Dec 2013)
- Legal Name Zestra, Inc
- Total Equity Funding$7.21M (USD)
in 2 rounds
- Latest Funding Round$4.1M (USD), Series A
Dec 2010
- InvestorsInnovus Pharma
& 2 more
- Acquired byInnovus Pharma
(Dec 2013)
Products & Services of Semprae Laboratories
Semprae Laboratories offers a comprehensive portfolio of products and services, including Arousal Oil and 3 Single Use Packets.
A blend of botanical oils is provided to enhance women's arousal and sexual sensation, as supported by clinical evidence.
Convenient packets are supplied for on-the-go use, facilitating effortless enhancement of sexual experiences.
Funding Insights of Semprae Laboratories
Semprae Laboratories has successfully raised a total of $7.21M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.1 million completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.21M
- Total Rounds 2
- Last Round Series A — $4.1M
- First Round $3.11M
(Feb 2010)
- Investors Count 2
All 2 funding rounds of Semprae Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2010 | $4.1M | Series A | – | – | – |
| Feb 2010 | $3.11M | Series A | – | Quaker Partners, BRV | – |
3 investors in total: 3 institutional.
Investors in Semprae Laboratories
Semprae Laboratories has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Innovus Pharma, Quaker Partners and BR Venture Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital investments are provided by BR Venture Fund. | brventurefund.com | Ithaca, United States | ||
| quakerbio.com | ||||
Science-backed dietary supplements are developed for everyday wellness. | 2011 | innovuspharma.com | San Diego, United States |
Investor details for Semprae Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Semprae Laboratories
4 dated milestones of Semprae Laboratories across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Semprae Laboratories is founded.
- Funding First funding round of $3.1M.
- Funding Latest funding round, Series A, of $4.1M.
- Exit Acquired by Innovus Pharma.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Semprae Laboratories (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Semprae Laboratories
Semprae Laboratories was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Semprae Laboratories is headquartered in Saddle Brook, United States. It is registered at Saddle Brook, New Jersey, United States.
Semprae Laboratories is a funded company, having raised a total of $7.21M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.11M, raised on Feb 2010.
Semprae Laboratories was founded in 2008 and is based in Saddle Brook, United States. Operations focus on the production of cold-pressed oils derived from seeds and nuts, using a method without filtration additives to maintain nutritional properties. Oil cakes, serving as high-fiber byproducts, are also generated, along with seed and nut flours for culinary applications. Ecological practices and quality raw materials are prioritized throughout the process.
Semprae Laboratories offers Arousal Oil and 3 Single Use Packets.
Semprae Laboratories has 3 investors. Key investors include Innovus Pharma, Quaker Partners, and BR Venture Fund.
Semprae Laboratories operates through Zestra, Inc.
Yes. Semprae Laboratories was acquired by Innovus Pharma in December 2013.